Conference Coverage
Conference Coverage
Serum Nf-L shows promise as biomarker for BMT response in MS
An analysis of paired samples suggests a valuable role for serum Nf-L in predicting MS severity and treatment response.
Conference Coverage
Aspirin May Be an Effective Pretreatment for Exercise in Patients With MS
LOS ANGELES>—Aspirin may be an effective pretreatment for exercise in patients with multiple sclerosis (MS), according to a study described at...
Conference Coverage
A Rational Approach to Starting, Stopping, and Switching DMTs
NASHVILLE—What guides decisions to start, stop, switch, or restart disease-modifying therapy (DMT) in patients with multiple sclerosis (MS)—...
Conference Coverage
Fitbit Flex is feasible, provides nuanced step count data in MS patients
Conference Coverage
Lipid Metabolism May Be a Therapeutic Target in MS
NASHVILLE—Multiple sclerosis (MS) traditionally has been considered a chronic inflammatory autoimmune disease, but inflammation decreases as the...
Conference Coverage
Ozanimod May Provide Better MS Outcomes Than Interferon Beta
NASHVILLE—Two doses of ozanimod provide greater benefits on annualized relapse rate and MRI end points than interferon beta-1a...
Conference Coverage
CMSC Guideline Re-Examines Use of Gadolinium-Based Contrast Agents
NASHVILLE—Gadolinium-based contrast agents (GBCAs) are necessary for the accurate initial diagnosis of patients experiencing a...
Conference Coverage
Eating Fish May Be Associated With a Reduced Risk of MS
LOS ANGELES—Eating fish at least once per week or eating fish one to three times per month, in addition to taking daily fish oil...
Conference Coverage
High-Intensity Interval Exercise May Be Appropriate for Patients With MS
NASHVILLE—For patients with multiple sclerosis (MS) and walking impairments, high-intensity interval exercise is as enjoyable as...
Conference Coverage
Reducing the Risk of PML During MS Treatment
NASHVILLE—For patients with multiple sclerosis (MS) who receive treatment with natalizumab, progressive multifocal...